Small-Molecule Compound XJH05 Ointment · Plaque Psoriasis
Enrollment reduced: 5 → 3 participants
Xijing HospitalNot applicable NCT07780929 Registry history of NCT07780929 on ClinicalTrials.gov (opens the registry)
Updated
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
Enrollment reduced: 5 → 3 participants
Xijing HospitalNot applicable NCT07780929 Registry history of NCT07780929 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Xijing HospitalNot applicable NCT07071402 Registry history of NCT07071402 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Xijing HospitalNot applicable NCT06834412 Registry history of NCT06834412 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Xijing HospitalNot applicable NCT06580249 Registry history of NCT06580249 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07876154 Iparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant… | Phase 2 | Recruiting |
| 2026-10-13 | NCT07871006 Ofatumumab in Treatment-Refractory¬ Narcolepsy Type 1 | Phase 1/2 | Recruiting |
| Early Phase 1 | 3 | |
| Phase 1 | 3 | |
| Phase 1/2 | 4 | |
| Phase 2 | 16 | |
| Phase 2/3 | 2 | |
| Phase 3 | 5 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07352228 | Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of… | Rebleeding of Portal Hypertension in Liver Cirrhosis | Enrolling by Invitation | 2026-01-20 |
| NCT05512910 | Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar… | Ischemic Stroke, Acute | Active, Not Recruiting | 2025-05-30 |
| Phase 3 | ||||
| NCT06702553 | Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass | Nitric Oxide | Recruiting | 2026-05-29 |
| NCT07116733 | Desflurane vs. Propofol for Cardiac Anesthesia | Cardiac Surgery | Recruiting | 2025-11-25 |
| NCT07271875 | Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal Surgery | Postoperative Gastrointestinal Dysfunction (POGD) | Not Yet Recruiting | 2025-12-09 |
| NCT07129031 | Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of… | Hemorrhage | Not Yet Recruiting | 2025-08-19 |
| NCT06982196 | Sulodexide in Controlling the Recurrence of Psoriasis | Psoriasis (PsO) | Enrolling by Invitation | 2025-05-21 |
| Phase 2/3 | ||||
| NCT07535593 | Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of… | Disorders of Consciousness Due to Severe Brain Injury | Recruiting | 2026-08-05 |
| NCT06769919 | A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy… | Breast Cancer | Not Yet Recruiting | 2025-01-10 |
| Phase 2 | ||||
| NCT07876154 | Iparomlimab/Tuvonralimab Combined With Nab-paclitaxel and Cisplatin as Neoadjuvant… | Locally Advanced Cervical Cancer | Recruiting | 2026-10-15 |
| NCT07788196 | A Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy… | IB-II Gastric Cancer | Recruiting | 2026-08-26 |
| NCT06914440 | Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast… | Breast Cancer | Recruiting | 2026-08-14 |
| NCT07750951 | Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab… | MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma | Recruiting | 2026-08-06 |
| NCT06572267 | Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease | Coronary Artery Disease | Recruiting | 2026-01-23 |
| NCT06993714 | 3D-printed Biodegradable Breast Implants for Breast Restoration | Breast Cancer | Recruiting | 2025-06-06 |
| NCT06586242 | Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy | Esophageal Cancer | Recruiting | 2024-09-19 |
| NCT06575257 | Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer | Prostate Cancer | Recruiting | 2024-08-28 |
| NCT07819604 | Serplulimab Combined With CAPOX and Bevacizumab as Neoadjuvant Therapy for Locally… | Locally Advanced Colorectal Cancer | Not Yet Recruiting | 2026-09-15 |
| NCT06576921 | Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment… | Stomach Neoplasms | Active, Not Recruiting | 2026-09-10 |
| NCT05558722 | Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone… | Breast Cancer Stage II | Active, Not Recruiting | 2026-06-10 |
| NCT07466303 | Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for… | Breast Cancer | Not Yet Recruiting | 2026-03-12 |
| NCT07333937 | Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced… | Brest Cancer | Not Yet Recruiting | 2026-01-12 |
| NCT07273981 | Zanidatamab Combined With Chemotherapy as Neoadjuvant Therapy for HER2-high Expression… | Gastric/Gastroesophageal Junction Adenocarcinoma | Not Yet Recruiting | 2025-12-10 |
| NCT07007780 | Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC | Triple -Negative Breast Cancer | Not Yet Recruiting | 2025-07-29 |
| NCT06459921 | Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase… | Neoadjuvant Chemotherapy | Not Yet Recruiting | 2024-10-10 |
Heart Disease (23) · Breast Cancer (15) · Coronary Artery Disease (10) · Gastric Cancer (9) · Prostate Cancer (9) · Stroke (8) · Epilepsy (6) · Melanoma (6) · Ulcerative Colitis (5) · Colorectal Cancer (4)